Tecnimede Group
Antonio Donato has a diverse work experience spanning various industries. Antonio started their career at Farmalabor in 1999, working in production until 2001. Antonio then joined Grünenthal from 2002 to 2009, where they held roles in business development, marketing, and sales. In 2007, they also took up a position as an invited assistant at the University of Coimbra. Currently, they are the CEO of Tecnimede Group, a role they assumed in June 2022. Additionally, they are a board member of the company, a position they have held since December 2009. Antonio Donato's experience showcases their expertise in management, marketing, sales, and production within the pharmaceutical and medical sectors.
Antonio Donato pursued their education with a strong focus on both business and pharmaceutical sciences. From 1985 to 1990, they attended the Universidade de Coimbra, where they obtained a Graduate degree in Pharmaceutical Sciences. This laid the foundation for their understanding of the pharmaceutical industry. Later, from 2003 to 2005, they enrolled at the ISEG - Lisbon School of Economics & Management, where they pursued an MBA degree in Gestao. This further enhanced their business acumen and management skills. These educational experiences reflect Antonio Donato's dedication to acquiring knowledge and expertise in both pharmaceutical sciences and business administration.
This person is not in any teams
Tecnimede Group
1 followers
TECNIMEDE GROUP is composed by pharmaceutical companies of private and 100% Portuguese capital. Started its activity in 1980 and covers the entire life cycle of the medicinal products for human use: development, manufacture, promotion and marketing. TECNIMEDE GROUP's strategy is based on a strong investment in Research, Development and Production of Medicinal Products. It is intended that the results obtained allow to consolidate the Group's position in the Portuguese market and to strengthen exports and internationalization. Atlantic Pharma Brasil and Atlas Pharm (Morocco) are an example of the Group's expansion and development of manufacturing plants. The TECNIMEDE GROUP’s commercial activity is based on: - The solid positioning of the three commercial lines in Portugal; - The direct presence in Spain, Italy, Morocco, Colombia and Brazil; - The establishment of local partnerships in the more than 40 countries where it exports — almost all the European Union countries, as well as several countries in Africa, South America, North America, Asia and the Middle East. TECNIMEDE GROUP's portfolio includes more than 100 products, as a result of its R&D center, which results in more than 2,500 MAs worldwide. Our Mission is the "Improvement and preservation of human life and health through the development, production and marketing of pharmaceutical products with a strong focus on quality and technological innovation.